Document is current
Any future updates will be listed below
-
Authors
Lee, Hye Won
Díaz, Luis Antonio
Wong, Vincent Wai-Sun https://orcid.org/0000-0003-2215-9410
Chan, Wah Kheong
-
Funding
Funding for this research was provided by:
Research Grants Council, University Grants Committee (14106824)
National Health Commission of the People's Republic of China (2023ZD0508700)
- License Information
-
More Information
Article History
Received: 2 July 2026
Accepted: 13 August 2026
First Online: 13 September 2026
Declarations
Conflict of interest: Vincent Wong has served as a consultant or advisory board member for AbbVie, Altimmune, AstraZeneca, Boehringer Ingelheim, Echosens, Eli Lilly, Gilead Sciences, Merck, Novartis, Novo Nordisk, Pfizer, Roche Diagnostics, TARGET PharmaSolutions; a speaker for Abbott, AbbVie, AstraZeneca, Echosens, Gilead Sciences, Novo Nordisk; an independent non-executive director for Furui; and a co-founder for Illuminatio Medical Technology. He has received a research grant from Gilead Sciences. Wah Kheong Chan has served as a consultant or advisory board member for Abbott, AbbVie, Boehringer Ingelheim, IPSEN, Kowa, Novo Nordisk, Roche and Zuellig Pharma, a speaker for Abbott, Boehringer Ingelheim, Duopharma, Echosens, Hisky Medical, Novo Nordisk, Roche, Taisho and Viatris, and received research grant from Abbott and Roche.
